Concepedia

Author

Noboru Kamada

Kissei Pharmaceutical (Japan)

Also Known As

Kamada, Noboru, Noboru KAMADA, Noboru Kamada

25

Publications

395

Citations

12

H-Index

23

Concepts

All Affiliations

Kissei Pharmaceutical (Japan)Tokyo University of Science
NK

About

Noboru Kamada is an author at Kissei Pharmaceutical (Japan) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

198

2

Biochemistry

7

7

175

3

Natural Sciences

3

3

80

4

Engineering

1

1

19

5

Biomolecular Engineering

1

1

19

Noboru Kamada

×

14

Publications

377

Citations

12

H-Index

YearCitations

An Efficient Method for Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-like Cells Retaining Drug Metabolizing Activity

Yuki Kondo, Takahiro Iwao, Katsunori Nakamura,

Drug Metabolism and Pharmacokinetics

2013

57

Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke

Harunobu Mukaiyama, Toshihiro Nishimura, Satoko Kobayashi,

Bioorganic & Medicinal Chemistry

2006

53

Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade

Harunobu Mukaiyama, Toshihiro Nishimura, Satoko Kobayashi,

Bioorganic & Medicinal Chemistry

2007

43

The Advantages of the Ussing Chamber in Drug Absorption Studies

Yasumasa Gotoh, Noboru Kamada, Den-ichi Momose

SLAS DISCOVERY

2005

37

Fourteen Chamigrane Derivatives from a Red Alga, <i>Laurencia nidifica</i>

Junji Kimura, Noboru Kamada, Yoshikazu Tsujimoto

Bulletin of the Chemical Society of Japan

1999

35

Discovery of Novel 2-Anilinopyrazolo[1,5-a]pyrimidine Derivatives as c-Src Kinase Inhibitors for the Treatment of Acute Ischemic Stroke

Harunobu Mukaiyama, Toshihiro Nishimura, Hiroaki Shiohara,

Chemical and Pharmaceutical Bulletin

2007

31

Synthesis of 2-(substituted methyl)quinolin-8-ols and their complexation with Sn(II)

Chitoshi Kitamura, Naoyuki Maeda, Noboru Kamada,

Journal of the Chemical Society Perkin Transactions 1

2000

19

Structure–activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia

Nobuhiko Fushimi, Hideki Fujikura, Hiroaki Shiohara,

Bioorganic & Medicinal Chemistry

2012

19

Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides

Masahiro Hiratochi, Kazuya Tatani, Kazuo Shimizu,

European Journal of Pharmacology

2012

19

Design, synthesis, and structure–activity relationships of a series of 4-benzyl-5-isopropyl-1H-pyrazol-3-yl β-d-glycopyranosides substituted with novel hydrophilic groups as highly potent inhibitors of sodium glucose co-transporter 1 (SGLT1)

Nobuhiko Fushimi, Hirotaka Teranishi, Kazuo Shimizu,

Bioorganic & Medicinal Chemistry

2012

15

Page 1